References in periodicals archive ?
JMML patients do achieve complete remission and long-term cure after a second bone marrow transplant.
The sense of community spirit that kept Charlotte at number one was truly overwhelming and raised over pounds 1,000 for vital research and awareness into JMML. We remain eternally grateful to all of our family, friends, schools, parishioners and Gazette readers who continued to support us so generously.
In the next two to three months, she will be undergoing several other procedures that would bring her safely to a bone marrow transplant, the only treatment option for JMML.
A year ago Michael and Claire Wren, of Marton, launched The Charlotte Wren Forget Me Not Fund to raise awareness and funds for Juvenile Myelomonocytic Leukaemia (JMML) after losing their daughter Charlotte in June 2007.
The Charlotte Wren Forget Me Not Fund was launched in July and has already raised more than pounds 38,800 to pay for research into JMML and to sponsor a room in Charlotte's name at Crawford House, which provides free accommodation for families.
A month later her parents, Michael and Claire Wren, of Marton, launched The Charlotte Wren Forget Me Not Fund to raise awareness and funds for Juvenile Myelomonocytic Leukaemia (JMML).
LAUNCHED on July 15 in loving memory of our beautiful three-year-old girl Charlotte, who sadly fell asleep one last time in the arms of her mammy and daddy on June 12 after an inspirationally courageous battle for life to a rare childhood leukaemia known as juvenile myelomonocytic leukaemia (JMML).
The Charlotte Wren Forget Me Not Fund was set up by Michael and Claire Wren, of Marton, Middlesbrough, in memory of their "pink princess" who lost her battle with a rare childhood leukaemia known as Juvenile Myelomonocytic Leukaemia (JMML) in June.
Charlotte Wren lost her battle with a rare childhood Leukaemia known as Juvenile Myelomonocytic Leukaemia (JMML) in June.
The collaboration with the National Cancer Institute as well as one with a Center of Excellence in Juvenile Myelomonocytic Leukemia, or JMML, for preclinical studies of rigosertib for treatment of pediatric cancer associated RASopathies are ongoing.
Acronyms browser ?
Full browser ?
- JMM Fernandez